HK1009650A1 - Adenosine derivatives - Google Patents
Adenosine derivatives Download PDFInfo
- Publication number
- HK1009650A1 HK1009650A1 HK98110345A HK98110345A HK1009650A1 HK 1009650 A1 HK1009650 A1 HK 1009650A1 HK 98110345 A HK98110345 A HK 98110345A HK 98110345 A HK98110345 A HK 98110345A HK 1009650 A1 HK1009650 A1 HK 1009650A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- formula
- compound
- group
- adenosine
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8729994 | 1987-12-23 | ||
| GB878729994A GB8729994D0 (en) | 1987-12-23 | 1987-12-23 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1009650A1 true HK1009650A1 (en) | 1999-06-04 |
| HK1009650B HK1009650B (en) | 1999-06-04 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0322242B1 (en) | Adenosine derivatives | |
| US6455510B1 (en) | Chemical Compounds | |
| US5547941A (en) | Cyclic dinucleoside diphosphorothioates, related compounds and pharmaceutical compositions | |
| EP0602454B1 (en) | N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines | |
| US6740644B2 (en) | Chemical compounds | |
| EP0286425B1 (en) | Therapeutic nucleosides | |
| HU211914A9 (en) | 2,6-diaminopurine derivatives | |
| HUP0301330A2 (hu) | 2-Aminokarbonil-9H-purin-származékok | |
| EP0539479B1 (en) | Heterocyclic compounds | |
| NZ244875A (en) | Adenosine derivatives and pharmaceutical compositions | |
| AU616914B2 (en) | Therapeutic necleosides | |
| US20040162422A1 (en) | Chemical compounds | |
| EP0421819A1 (en) | Therapeutic nucleosides | |
| US3929763A (en) | N(6)-disubstituted adenosine compounds | |
| US3920630A (en) | 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation | |
| US6242429B1 (en) | Arabinosyladenine derivatives | |
| HK1009650B (en) | Adenosine derivatives | |
| EP0572669A1 (en) | 1-B(beta)-D-Arabinofuranosyl-(E)-5-(2-halogenovinyl)-uracil-derivative | |
| US3966916A (en) | N(6)-disubstituted adenoisine compounds and therapeutic compositions | |
| US4016262A (en) | Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds | |
| US3929764A (en) | N(6)-disubstituted adenosine compounds | |
| HK1039935A1 (en) | Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv | |
| JPH05163294A (ja) | ２−置換アデノシン誘導体および循環器疾患用薬 | |
| FR2663936A1 (fr) | Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |